Glucose + Nacl, Viaflo Baxter

Viaflo Baxter Glucose + NaCl is an intravenous solution that contains glucose and sodium chloride. It is supplied as a sterile liquid for infusion and is marketed in the European Union. The formulation provides both carbohydrate and electrolyte support, helping to maintain fluid balance and energy levels in patients who require intravenous therapy, such as during surgery, postoperative care, or treatment of hypoglycemia or dehydration.

Viaflo Baxter Glucose + NaCl is used as an intravenous fluid to provide both carbohydrate and electrolyte replacement in a range of clinical situations. It is appropriate when rapid fluid, energy, or sodium supplementation is needed in hospital or emergency settings.

- Fluid and electrolyte replacement for patients with dehydration or hypovolemia. - Source of carbohydrate for patients unable to take oral nutrition. - Peri‑operative and post‑operative care to maintain fluid balance. - Management of mild hypoglycemia when oral glucose is not feasible. - Support during renal replacement therapy or continuous infusion protocols.

Side effects reported with intravenous glucose and sodium chloride solutions are generally related to the infusion itself or to the metabolic impact of the ingredients.

Common: - Mild local irritation or pain at the infusion site. - Transient hyperglycemia, especially in patients with impaired glucose tolerance. - Slight increase in serum sodium levels. - Mild electrolyte imbalance such as hypernatremia. - Low-grade fever or chills related to infusion.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Marked hypernatremia causing neurological symptoms. - Fluid overload with pulmonary edema. - Allergic reaction or anaphylaxis to solution components. - Infection at the catheter site.

When using Viaflo Baxter Glucose + NaCl, clinicians should consider patient‑specific factors and monitor relevant parameters to ensure safe administration.

- Assess blood glucose and serum electrolytes before and during infusion. - Adjust infusion rate in patients with renal or cardiac insufficiency. - Avoid rapid infusion in neonates or patients at risk of fluid overload. - Use aseptic technique to prevent catheter‑related infections. - Monitor for signs of hyperglycemia or hypernatremia. - Consider alternative solutions for patients with known intolerance to glucose or sodium chloride.

Glucose and sodium chloride solutions can interact with other medications or clinical conditions, influencing safety and effectiveness.

Avoid: - Co‑administration with high‑dose insulin without glucose monitoring. - Simultaneous infusion of drugs that require a specific pH or osmolarity environment. - Use in patients receiving hypertonic saline solutions without adjusting total sodium load.

Use with caution: - Concurrent diuretics that may alter electrolyte balance. - Medications that affect renal function, such as ACE inhibitors or NSAIDs. - Blood‑sugar‑lowering agents in diabetic patients. - Vasopressors that may mask signs of fluid overload.